• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Comprehensive care of adults with respiratory diseases must include vaccines
Vaccines are among the most effective tools we have to improve and save lives, but only if they are administered to eligible patients. In this issue, Naeger et al1 highlight the major opportunities that the health care community has to achieve high adult vaccination rates. These vaccines include those for prevention of coronavirus disease 2019 (COVID-19), pneumococcal, and influenza, diseases that respiratory health professionals are most aware of, plus pertussis (in Tdap), herpes zoster (HZ, shingles), and as of May 3, 2023, respiratory syncytial viral, for which adults with asthma and chronic obstructive pulmonary diseas...
Source: Annals of Allergy, Asthma and Immunology - September 1, 2023 Category: Allergy & Immunology Authors: Barbara P. Yawn, Dennis Williams, Gregory Poland Tags: Editorial Source Type: research

Increasing the percentage of patients that receive the influenza vaccine in allergy shot clinics
Vaccinations are a critical component of routine healthcare, and studies reveal that patients are more likely to receive vaccinations when they are recommended by a medical provider. In the US, annual influenza vaccine rates were 48.4% during the 2019-20 influenza season and 50.2% during the 2020-21 influenza season. The US Healthy People 2030 target goal is 70%.
Source: Annals of Allergy, Asthma and Immunology - November 1, 2022 Category: Allergy & Immunology Authors: L. Flettrich, J. Gubin, M. Tankersley Tags: P045 Source Type: research

Brachial neuritis from the mrna sars-cov-2 and influenza vaccines
We report a case of brachial neuritis after the second mRNA SARS-CoV-2 which recurred after a subsequent influenza vaccine.
Source: Annals of Allergy, Asthma and Immunology - November 1, 2022 Category: Allergy & Immunology Authors: J. VanLancker, D. Sheth Tags: M047 Source Type: research

Modulation of Immune Responses Against HA1 Influenza Vaccine Candidate by B-lymphocyte Stimulator Cytokine in Mice
Iran J Allergy Asthma Immunol. 2022 Apr 11;21(2):207-214. doi: 10.18502/ijaai.v21i2.9228.ABSTRACTUtilizing subunit vaccines is one of the strategies to address influenza infection. Recent innovations have focused on high doses of vaccine antigens and immune enhancers or adjuvant to induce more robust and long-lasting immune responses. Here, an effect of the B cell-activating factor receptor (BAFF-R) to increase the magnitude and durability of immune responses of the recombinant HA1 (rHA1) protein against the H1N1 influenza virus was studied. The HA1 protein and the effector domain of BAFF-R were expressed in the pET-28a (+...
Source: Iranian Journal of Allergy, Asthma and Immunology - May 1, 2022 Category: Allergy & Immunology Authors: Seyedeh Mahsa Bagheri Yazdi Shahla Shahsavandi Fatemeh Fotouhi Majid Tebianian Mohammad Majid Ebrahimi Source Type: research

Recurrent Pneumonia Related to a Haemophilus influenzae-Specific Antibody Deficiency and its Alleviation by Vaccination
Ann Allergy Asthma Immunol. 2022 Apr 8:S1081-1206(22)00292-7. doi: 10.1016/j.anai.2022.03.032. Online ahead of print.NO ABSTRACTPMID:35405359 | DOI:10.1016/j.anai.2022.03.032
Source: Annals of Allergy, Asthma and Immunology - April 11, 2022 Category: Allergy & Immunology Authors: Samantha Nguyen Merin Anna Reji Aaisha Haque Guha Krishnaswamy Source Type: research

Pages: 1  2  3  4  5  6  7